Header Logo

Connection

Lesley Scott to Fusion Proteins, bcr-abl

Back to Details
This is a "connection" page, showing publications Lesley Scott has written about Fusion Proteins, bcr-abl.
Lesley Scott
Connection Strength
0,031
Fusion Proteins, bcr-abl
  1. Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients. Leukemia. 2015 Jul; 29(7):1514-23.
    View in: PubMed
    Score: 0,031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.